Gylys questioned why continued nicotine replacement therapy (NRT) use rates were not reported in our study.1 The introductory section of our article concluded with a clear statement that findings regarding the products' dependence potential will be reported separately. This article has been accepted for publication in Psychopharmacology, and it will appear shortly.2 There was never any intention not to report these findings. Gylys came to this conclusion on the basis of misinterpreting a sentence from another context. Like Gylys, we consider this topic important. Indeed, we examined this in sufficient depth to warrant a full separate report.
Hajek P, West R. Continued Dependence on Nicotine Replacement Therapy Should Be Reported and Discussed in Smoking Cessation Trials—Reply. Arch Intern Med. 2000;160(13):2061–2067. doi:
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.